This paper describes a prospective follow-up of 364 evidence, together with follow-up of the patients still living and those who died without autopsy, revealed a patients initially notified as suspected Creutzfeldt-Jakob disease to a Surveillance Unit in Göttingen, Germany. Six broad range of other diagnoses. In the younger age groups, the commonest were chronic inflammatory patients were diagnosed as having genetic prion disease by blood analysis and were excluded from the study. 
Introduction
With the increasing awareness of the transmissible Arpino et al., 1999) . Will and Matthews analysed 147 cases from the UK, comparing the cause of death on the death spongiform encephalopathies, the reported incidence of sporadic Creutzfeldt-Jakob disease now exceeds the certificate with the hospital notes (Will and Matthews, 1984) . Using criteria formulated by Masters and colleagues (Masters commonly accepted figure of 1 per million population per year (Hainfellner et al., 1996) . The prospective surveillance et al., 1979) , they felt that 42 did not, in fact, have CreutzfeldtJakob disease. Brown and colleagues reported on 1113 brains programmes in many countries within the BIOMED project of the European Community have all yielded similar and from persons where Creutzfeldt-Jakob disease was a possible diagnosis (Brown et al., 1994) . In 300 cases a transmissible slightly increasing figures . This increase is particularly pronounced in cases notified as suspected spongiform encephalopathy was found and of these 234 were classified as sporadic Creutzfeldt-Jakob disease. In Italy the Creutzfeldt-Jakob disease. However, a significant number of these are eventually found not to have the disease. In Britain proportion of misclassification for death certificates was 35.6% for the year 1993 (Arpino et al., 1999) . only about half of all suspected cases are found to fulfil the criteria for definite or probable Creutzfeldt-Jakob disease
In these studies the disorders leading to death had apparently so many clinical similarities to Creutzfeldt-Jakob (Will and Zeidler, 1996) . This figure is given in an editorial without further information on the diagnoses of the nondisease that this diagnosis appeared either on the death certificate, or the brain was sent to the National Institutes for Creutzfeldt-Jakob disease cases.
There are three studies in the literature in which the Health, Bethesda, Md., USA for transmission studies. The wide spectrum of non-Creutzfeldt-Jakob disease disorders accuracy of a Creutzfeldt-Jakob disease diagnosis was evaluated (Will and Matthews, 1984; Brown et al., 1994;  shows that the clinical diagnosis of Creutzfeldt-Jakob disease is difficult during life. Although Creutzfeldt-Jakob disease is still a fatal non-treatable disease, the correct diagnosis as early as possible is important for two reasons: (i) so that rare treatable dementias such as Hashimoto encephalitis are not missed, and (ii) to support clinicians and relatives in their decisions regarding further therapeutic steps. Up to now, the EEG was the only well-established technical investigation in the differential diagnosis of CreutzfeldtJakob disease. Only recently, the value of CSF markers (Hsich et al., 1996; Zerr et al., 1998) and the technique of Fig. 1 Original classification of living Creutzfeldt-Jakob disease MRI (Finkenstaedt et al., 1996) were recognized as diagnostic patients according to the extended epidemiological criteria of tools for the diagnosis of Creutzfeldt-Jakob disease. Masters and colleagues (Masters et al., 1979) . This paper is a prospective follow-up of all patients notified as having suspected Creutzfeldt-Jakob disease in Germany over a 3-year period. The features that help to distinguish it University of Göttingen. The 14-3-3 protein immunoassay in CSF was performed as described by Zerr and colleagues from other diseases are discussed and, in particular, there is an assessment of the recently described 14-3-3 protein in (Zerr et al., 1998) . Detection of the bound polyclonal antibody to the β-isoform of the 14-3-3 protein (Santa Cruz Biotech, CSF (Hsich et al., 1996; Zerr et al., 1998) as a diagnostic marker of Creutzfeldt-Jakob disease. Because this Santa Cruz, Calif., USA) was performed using the enhanced chemiluminescence detection kit (Amersham Buchler, epidemiological study was primarily concerned with the sporadic form of Creutzfeldt-Jakob disease, familial cases Freiburg, Germany). A positive control from a case with confirmed Creutzfeldt-Jakob disease and a negative control were excluded when genotyping revealed a genetic prion disease. Iatrogenic cases were also excluded.
were run on every gel. All the cases were initially classified into three groups: probable Creutzfeldt-Jakob disease, possible CreutzfeldtJakob disease and other disease. A definite diagnosis of
Methods
In Germany, all patients with suspected Creutzfeldt-Jakob Creutzfeldt-Jakob disease was only made if there was confirmation by autopsy. The criteria used in the classification disease are notified to the Creutzfeldt-Jakob Disease Surveillance Unit which is located in Göttingen. From June were those of Masters and colleagues (Masters et al., 1979) . Probable Creutzfeldt-Jakob disease was diagnosed if patients 1993 to May 1996, a total of 364 cases were notified. They came from treating physicians in Neurological and Psychiatric had rapidly progressive dementia, periodic sharp waves in the EEG and at least two of the following four findings: Departments all over Germany. After informed consent was given by the relatives, the patients were seen by a physician myoclonus, visual and/or cerebellar symptoms, pyramidal and/or extrapyramidal signs, and akinetic mutism. Those from the Surveillance Unit and had a detailed neurological examination. Clinical data based on a semi-structured cases who fulfilled the above criteria but did not have a typical EEG were originally classified as possible Creutzfeldtinterview was obtained from the patient's relatives. The hospital records were examined, a full medical history and Jakob disease. The recent extension of these criteria, which utilizes the presence of 14-3-3 protein in CSF allowed the the results of any investigations were obtained and the differential diagnosis was discussed with the treating reclassification of a number of possible Creutzfeldt-Jakob disease cases into the probable category. Thus, a patient who physician.
The EEG was evaluated using the criteria of Steinhoff and presented with a typical clinical picture, but without periodic sharp wave complexes on the EEG, was classified as a colleagues: periodic sharp wave complexes were diagnosed if the record contained strictly periodic cerebral potentials, probable case if 14-3-3 protein had been found in the CSF. These extended criteria have been applied to the cases in the majority had a duration of between 100 and 600 ms and there was an inter-complex interval between 500 and 2000 ms this paper (Fig. 1) . The classification 'other disease' was made if: (i) either dementia was insufficiently documented (Steinhoff et al., 1996) . If available, CT scans and MRI studies were analysed. The MRI was considered typical of or had been present for over 2 years; (ii) there was a lack of the typical neurological symptoms and signs; and (iii) there Creutzfeldt-Jakob disease if it showed bilateral areas of increased signal intensity predominantly affecting the caudate was CSF evidence of an inflammatory disease process. The clinical diagnosis of Alzheimer's disease was made nuclei and the putamina on long repetition time images (Finkenstaedt et al., 1996) . In patients who could be tested, using the NINCDS-ADRDA criteria (McKhann et al., 1984) . Hashimoto encephalitis was diagnosed if there was a dementia was diagnosed when the Mini-Mental State Examination score was less than 24 out of 30.
significant elevation of anti-thyroid autoantibodies in the serum and the typical findings of a Hashimoto thyroiditis CSF samples and blood were obtained in the majority of cases after informed consent was obtained from a relative or (Ghika-Schmid et al., 1996; Kothbauer-Margreiter et al., 1996; Seipelt et al., 1999) . guardian and approval by the Ethics Committee of the During follow-up, patients were assessed and reclassified in the autopsy revealed Alzheimer's disease. The tracings clearly show the appearance of periodic sharp wave complexes accordance with the development of their disease. Hospital notes and discharge summaries were regularly reviewed, and during the course of the disease.
Of the 54 possible Creutzfeldt-Jakob disease cases, 21 family physicians and neurologists, nursing homes and relatives were contacted to obtain information about the clinical came to autopsy. Ten were shown to have another diagnosis. Four had Alzheimer's disease, two encephalitis, two vascular progress of the illness and the results of any investigations performed. Autopsies were performed by the local neurodementias, one unclassified dementia and one hypoxic brain damage. As already indicated, the EEG was not typical for pathologist and/or the Reference Centre for Creutzfeldt-Jakob disease in Göttingen. A definite diagnosis of Creutzfeldt-Jakob
Creutzfeldt-Jakob disease in these cases and the 14-3-3 protein was either negative or CSF was not available. disease was made when there were the typical neuropathological changes of spongiform degeneration, gliosis and nerve
Of the 111 other disease cases, 20 came to autopsy. Of these, two were shown to have Creutzfeldt-Jakob disease. cell loss, and pathological prion protein deposits in brain tissue, detected immunohistologically using monoclonal antibody Both had typical neurological symptoms and signs during the course (myoclonus, akinetic mutism). No dementia was Gö138 or 3F4 (Kretzschmar et al., 1996) . present in one case after 6 months of illness. The other developed aphasia 3 months after onset and before a dementing process could be verified. Although the EEG was
Results
Of the 364 cases, six were excluded from further study when not typical, 14-3-3 protein was positive in the CSF of both patients. Unfortunately, MRI was not available in the majority they were identified as having a genetic prion disorder. The initial classification of the remaining 358 using the extended of these reclassified cases.
In Table 2 the final diagnoses of the other disease criteria of Masters and colleagues (Masters et al., 1979) , i.e. their criteria plus the presence of 14-3-3 protein, was: 193 classification are listed. There were 124 cases, comprising 109 from the original classification (two of the original 111 probable, 54 possible and 111 other disease (Fig. 1) . Note that on our initial assessment, we felt that almost one-third were found to have Creutzfeldt-Jakob disease and omitted), 10 from the possible group and five from the probable group. of the cases referred to us did not have Creutzfeldt-Jakob disease. Of the 358 cases, 136 autopsies were performed.
Autopsy or genetic testing was done on 37 cases, with clinical information and assessment being utilized for the patients Table 1 illustrates the results.
Of the 193 cases classified as probable Creutzfeldt-Jakob still alive and for those who died without autopsy. Alzheimer's disease was the commonest diagnosis, followed by undisease, 95 came to autopsy. Of these, five were shown not to have Creutzfeldt-Jakob disease. Four had Alzheimer's classified dementias, cerebrovascular disease and chronic encephalitis. There was a subgroup of 18 patients with chronic disease and one had a cerebral lymphoma. All five had dementia of less than 2 years' duration and all had myoclonus. inflammatory neurological diseases (chronic encephalitis, multiple sclerosis, paraneoplastic encephalopathies and Three had akinetic mutism, four had pyramidal signs and three had extrapyramidal signs. Visual and cerebellar signs Hashimoto encephalitis). The average age of this group of patients was markedly lower than the age of the rest of the were present in the patient with lymphoma but not in Alzheimer's disease cases. 14-3-3 protein was negative in patients (46 years versus 61 years). In this younger age group, a chronic inflammatory illness was the most frequent three cases and positive in one with Alzheimer's disease; CSF was not available in the case of lymphoma. At the time final diagnosis. Table 3 compares the clinical symptomatology for patients of classification, the EEG recordings were considered to be typical of Creutzfeldt-Jakob disease. A re-evaluation revealed who have Creutzfeldt-Jakob disease with those who have other diseases. At the time of notification, the frequency of that in two cases the original assessment was still valid, although the other three (two Alzheimer's disease, one neurological signs was higher in Creutzfeldt-Jakob disease patients with the exception of epilepsy. At the beginning lymphoma) may, in retrospect, not have fulfilled our criteria for probable Creutzfeldt-Jakob disease. In Fig. 2, two tracings of the disease, visual disturbances seemed to be the best discriminator between Creutzfeldt-Jakob disease and other at different dates are shown for a patient originally diagnosed as having probable Creutzfeldt-Jakob disease but for whom diseases (19% versus 1%). In Table 4 , a comparison is made of the sensitivity and Unfortunately, data protection laws make the exchange of information impossible between the two systems. specificity of the presence of 14-3-3 protein in CSF, the typical EEG recording and typical MRI in those patients
In Italy, a comparison between death certificates and the prospective Creutzfeldt-Jakob disease register revealed a where the tests were done. As can be seen, MRI is likely to become an important tool in the diagnosis of Creutzfeldtproportion of misclassification for the death certificates of 35.6% and under-reporting for the Creutzfeldt-Jakob disease Jakob disease. However, these are preliminary figures and further analysis will be required.
register of 26.7% for the first year of the prospective study. For 1996, the mortality rate per million of 1.11 obtained by the Creutzfeldt-Jakob disease register was considered to be complete.
Discussion
This is the first prospective study in which an attempt is At present, the most reliable incidence figures come from Austria where autopsy rates are over 90% for deaths in made to assess the reliability of an initial diagnosis of Creutzfeldt-Jakob disease. In regard to the question as to hospital. For the year 1995, Hainfellner and colleagues (Hainfellner et al., 1996) reported an incidence of 1.38 how often the diagnosis is missed, we cannot exclude the possibility that some cases are not notified to the Surveillance compared with 1.2 in Germany [extended criteria of Masters and colleagues (Masters et al., 1979) ]. Unit. However, the awareness of Creutzfeldt-Jakob disease is very high in Germany and co-operation with the notifying There are a large number of alternative diagnoses possible when Creutzfeldt-Jakob disease is suspected, either initially hospitals improved considerably during the time of the study. In addition, comparison with the mandatory notification or during the course of illness. This reflects the overlapping clinical symptomatology with a number of other diseases, system introduced in July 1994 showed that treating physicians notified their cases earlier and more often to particularly with rapidly progressive Alzheimer's disease. Visual symptoms discriminated best between Creutzfeldtthe Surveillance Unit than to the mandatory system. In addition one each of the following autopsy proven neurological disorders were found: leucodystrophy, fatal familial insomnia, congophilic angiopathy, lipoid histiocytosis, gliomatosis cerebri, hypoxic brain damage, astrocytoma. unselected Alzheimer's disease cases (Mayeux et al., 1985) .
Pareses and spasticity 52 25
The EEG falsely suggested Creutzfeldt-Jakob disease in Epileptic fits 12 27 five of our cases that were originally classified as probable Creutzfeldt-Jakob disease but proved at autopsy to have Table 4 Sensitivity and specificity of detection of 14-3-3 in Alzheimer's disease or lymphoma. This has been known to CSF, periodic sharp wave complexes in the EEG and occur in rare instances, mostly published as clinical reports hyperintense signals in long repetition-time MRIs (Watson, 1979; Steinhoff et al., 1996) . During the first period of our study, EEG criteria were not so strictly defined and this resulted in three of the five cases being classified as (n ϭ 289) (n ϭ 256) (n ϭ 213) when atrophy is most pronounced in the temporobasal and hippocampus regions. CT is also useful in diagnosing vascular dementia. MRI showed basal ganglia hyperintensity both in the diagnosis of Creutzfeldt-Jakob disease will eventually be comparable with that of the EEG. the proton-and T 2 -weighted images in 23 of 29 of our initial Creutzfeldt-Jakob disease cases (Finkenstaedt et al., 1996) .
The CSF findings were useful in both excluding inflammatory diseases and in making a diagnosis of In a recent re-evaluation of 157 MRI scans of definite and probable Creutzfeldt-Jakob disease cases and of 56 other Creutzfeldt-Jakob disease. Twelve out of the 18 patients with chronic inflammatory processes had either pleocytosis and/or cases, the sensitivity was 67% and the specificity 93% (our unpublished results). It is likely that the value of MRI for an oligoclonal appearance of the CSF γ-globulin region. On Creutzfeldt-Jakob disease at autopsy. Of these, five were probable and 10 possible cases. On the other hand, two *Our cases; † see Brown et al., 1994 ; ‡ see Will and Matthews, 1984. patients who were originally classified as other disease were diagnosed as having Creutzfeldt-Jakob disease at autopsy. Creutzfeldt-Jakob disease is difficult to reliably diagnose the other hand, determination of 14-3-3 protein was helpful in diagnosing Creutzfeldt-Jakob disease. Although 14-3-3 is clinically. Both false positive and false negative diagnoses occur. In some cases, a treatable dementia such as Hashimoto found in other neurological diseases with rapidly progressive brain damage such as herpes encephalitis, these acute encephalitis can be detected. We have shown that, by careful examination, appropriate laboratory investigations and regular disorders are easily recognized and 14-3-3 does not persist. In two of our cases with inflammatory disease, 14-3-3 became and systematic follow-up a more accurate diagnosis can be made. The greater use of EEG, MRI and specialized CSF negative after 3 weeks. We also found 14-3-3 protein in five cases, originally classified as other disease but who had no tests, when taken together with an accurate clinical history and careful examination, now allow an initial diagnosis of inflammatory findings. After autopsy, two were shown as having definite Creutzfeldt-Jakob disease, two had Creutzfeldt-Jakob disease to be made with increasing certainty. The category 'probable' can be called Creutzfeldtunclassified dementia and one a paraneoplastic syndrome. The detection of 14-3-3 is of most value in the differential Jakob disease for clinical purposes. diagnosis of Creutzfeldt-Jakob disease and Alzheimer's disease. In a recent review Johnson and Gibbs reported a sensitivity of 96% and a specificity of 99% for patients
